ProCE Banner Activity

COVID-19 Testing and Risk Stratification

Clinical Thought
Read our answers to key issues about SARS-CoV-2 testing and patient-specific risk stratification for determining COVID-19 treatment.

Released: December 20, 2022

Expiration: December 19, 2023

No longer available for credit.

Share

Faculty

Renslow Sherer

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Rasika Karnik

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Pfizer, Inc.

Program Director Disclosure

Program Director

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Renslow Sherer, MD: unrestricted research grant: Gilead Sciences.

Faculty Disclosure

Primary Author

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Rasika Karnik, MS, MD: consultant/advisor/speaker: Gilead Sciences.